Feedback / Questions
soquelitinib (CPI-818) - Corvus Pharma
https://www.marketbeat.com/instant-alerts/corvus-pharmaceuticals-highlights-soquelitinib-pipeline-eyes-phase-ii-atopic-dermatitis-trial-in-2026-2026-02-27/
Feb 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next